CLSD

Clearside Biomedical Inc
1.4499
0.1199 (9.02%)
Upgrade to Real-Time
Afterhours (Closed)
1.4499
Volume 121,755
Bid Price 1.29
Ask Price 1.45
News -
Day High 1.3865

Low
0.98

52 Week Range

High
2.85

Day Low 1.305
Company Name Stock Ticker Symbol Market Type
Clearside Biomedical Inc CLSD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.1199 9.02% 1.4499 16:35:37
Open Price Low Price High Price Close Price Prev Close
1.33 1.305 1.3865 1.33 1.33
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
549 121,755 $ 1.34 $ 163,164 - 0.98 - 2.85
Last Trade Time Type Quantity Stock Price Currency
18:58:45 4 $ 1.33 USD

Period:

Draw Mode:

Clearside Biomedical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 87.27M 60.19M 54.48M $ 29.58M $ -7.74M 0.01 -24.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.39M 9.10%

more financials information »

Clearside Biomedical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLSD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.481.58981.28251.40110,505-0.0301-2.03%
1 Month1.091.821.071.47248,7060.359933.02%
3 Months1.461.820.981.28294,936-0.0101-0.69%
6 Months1.631.830.981.31200,895-0.1801-11.05%
1 Year1.852.850.981.77402,489-0.4001-21.63%
3 Years2.757.730.983.44676,516-1.30-47.28%
5 Years6.4215.3290.563.67697,626-4.97-77.42%

Clearside Biomedical Description

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.